These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

57 related articles for article (PubMed ID: 28285725)

  • 1. Universal versus targeted additional contact precautions for multidrug-resistant organism carriage for patients admitted to an intensive care unit.
    Djibré M; Fedun S; Le Guen P; Vimont S; Hafiani M; Fulgencio JP; Parrot A; Denis M; Fartoukh M
    Am J Infect Control; 2017 Jul; 45(7):728-734. PubMed ID: 28285725
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effectiveness of tailored screening for multidrug-resistant organisms upon admission to an intensive care unit in the United Arab Emirates.
    Park S; Kim H; Gatchalian KK; Oh H
    Antimicrob Resist Infect Control; 2023 Nov; 12(1):135. PubMed ID: 38012753
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reducing Hospitalizations and Multidrug-Resistant Organisms via Regional Decolonization in Hospitals and Nursing Homes.
    Gussin GM; McKinnell JA; Singh RD; Miller LG; Kleinman K; Saavedra R; Tjoa T; Gohil SK; Catuna TD; Heim LT; Chang J; Estevez M; He J; O'Donnell K; Zahn M; Lee E; Berman C; Nguyen J; Agrawal S; Ashbaugh I; Nedelcu C; Robinson PA; Tam S; Park S; Evans KD; Shimabukuro JA; Lee BY; Fonda E; Jernigan JA; Slayton RB; Stone ND; Janssen L; Weinstein RA; Hayden MK; Lin MY; Peterson EM; Bittencourt CE; Huang SS;
    JAMA; 2024 May; 331(18):1544-1557. PubMed ID: 38557703
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development and validation of machine learning models to predict MDRO colonization or infection on ICU admission by using electronic health record data.
    Li Y; Cao Y; Wang M; Wang L; Wu Y; Fang Y; Zhao Y; Fan Y; Liu X; Liang H; Yang M; Yuan R; Zhou F; Zhang Z; Kang H
    Antimicrob Resist Infect Control; 2024 Jul; 13(1):74. PubMed ID: 38971777
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gut colonization with multidrug resistant organisms in the intensive care unit: a systematic review and meta-analysis.
    Heath MR; Fan W; Leu CS; Gomez-Simmonds A; Lodise T; Freedberg DE
    Crit Care; 2024 Jun; 28(1):211. PubMed ID: 38943133
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-Term Impact of Universal Contact Precautions on Rates of Multidrug-Resistant Organisms in ICUs: A Comparative Effectiveness Study.
    Furuya EY; Cohen B; Jia H; Larson EL
    Infect Control Hosp Epidemiol; 2018 May; 39(5):534-540. PubMed ID: 29562944
    [TBL] [Abstract][Full Text] [Related]  

  • 7. When Multidrug-Resistant Organism (MDRO)-Positive ICU Patient Isolation and Cohorting Is Not Feasible, What Comes Next?
    Iordanou S; Palazis L; Timiliotou-Matsentidou C; Mendris M; Raftopoulos V
    Cureus; 2021 Mar; 13(3):e13636. PubMed ID: 33659147
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mortality incidence among critically ill burn patients infected with multidrug-resistant organisms: A retrospective cohort study.
    Ellithy M; Mitwally H; Saad M; Mathias R; Shaukat A; Elzeer H; Hassan Koya S; Mahmood Z; Gazwi K
    Scars Burn Heal; 2021; 7():20595131211015133. PubMed ID: 34104480
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence of multidrug-resistant organisms in refugee patients, medical tourists and domestic patients admitted to a German university hospital.
    Reinheimer C; Kempf VA; Jozsa K; Wichelhaus TA; Hogardt M; O'Rourke F; Brandt C
    BMC Infect Dis; 2017 Jan; 17(1):17. PubMed ID: 28056820
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early Screening of Risk for Multidrug-Resistant Organisms in the Emergency Department in Patients With Pneumonia and Early Septic Shock: Single-Center, Retrospective Cohort Study.
    Yiang GT; Tzeng IS; Shui HA; Wu MY; Peng MY; Chan CY; Chan ED; Wu YK; Lan CC; Yang MC; Huang KL; Wu CW; Chang CH; Su WL
    Shock; 2021 Feb; 55(2):198-209. PubMed ID: 32694392
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of Daily versus Admission and Discharge Surveillance Cultures for Multidrug-Resistant Organism Detection in an Intensive Care Unit.
    Sansom SE; Shimasaki T; Dangana T; Lin MY; Schoeny ME; Fukuda C; Moore NM; Yelin RD; Bassis CM; Rhee Y; Cornejo Cisneros E; Bell P; Lolans K; Aboushaala K; Young VB; Hayden MK
    J Infect Dis; 2024 Mar; ():. PubMed ID: 38546721
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk of multi-drug-resistant organism acquisition from prior bed occupants in the intensive care unit: a meta-analysis.
    Gu GY; Chen M; Pan JC; Xiong XL
    J Hosp Infect; 2023 Sep; 139():44-55. PubMed ID: 37406860
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Incidence, risk factors and clinical outcome of multidrug-resistant organisms after heart transplantation.
    Hatzianastasiou S; Vlachos P; Stravopodis G; Elaiopoulos D; Koukousli A; Papaparaskevas J; Chamogeorgakis T; Papadopoulos K; Soulele T; Chilidou D; Kolovou K; Gkouziouta A; Bonios M; Adamopoulos S; Dimopoulos S
    World J Transplant; 2024 Jun; 14(2):93567. PubMed ID: 38947964
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of Infection Control Measures in Managing Outbreaks of Multidrug-Resistant Organisms in Burn Units.
    Wang C; Zhang F; Breland A; Lineaweaver WC
    Ann Plast Surg; 2021 Jun; 86(4S Suppl 4):S454-S457. PubMed ID: 33833187
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of infection control interventions in reducing the spread of multidrug-resistant organisms in the hospital setting.
    D'Agata EM; Horn MA; Ruan S; Webb GF; Wares JR
    PLoS One; 2012; 7(2):e30170. PubMed ID: 22363420
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevention and control of hospital-acquired infections with multidrug-resistant organism: A review.
    Ji B; Ye W
    Medicine (Baltimore); 2024 Jan; 103(4):e37018. PubMed ID: 38277558
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Universal screening or a universal risk assessment combined with risk-based screening for multidrug-resistant microorganisms upon admission: Comparing strategies.
    van der Schoor AS; Severin JA; Klaassen CHW; van den Akker JPC; Bruno MJ; Hendriks JM; Vos MC; Voor In 't Holt AF
    PLoS One; 2023; 18(7):e0289163. PubMed ID: 37490485
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fecal Carriage of Multidrug-Resistant Organisms Increases the Risk of Hepatic Encephalopathy in Cirrhotic Patients: Insights from Gut Microbiota and Metabolite Features.
    Wu P; Lee PC; Chang TE; Hsieh YC; Chiou JJ; Lin CH; Huang YL; Lin YT; Huo TI; Schnabl B; Lee KC; Hou MC
    Res Sq; 2024 May; ():. PubMed ID: 38766152
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A deep learning model for predicting multidrug-resistant organism infection in critically ill patients.
    Wang Y; Wang G; Zhao Y; Wang C; Chen C; Ding Y; Lin J; You J; Gao S; Pang X
    J Intensive Care; 2023 Nov; 11(1):49. PubMed ID: 37941079
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Towards a Definition for Health Care-Associated Infection.
    Friedman ND; Levit D; Taleb E; Marcus G; Michaeli L; Broide M; Mengesha B; Zaidenstein R; Lazarovitch T; Dadon M; Kaye KS; Marchaim D
    Open Forum Infect Dis; 2018 Jun; 5(6):ofy116. PubMed ID: 29942821
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.